Lindsey Montefiori

8PUBLICATIONS
153CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 05, 2026
Genomic drivers of leukemia and blinatumomab response in adult acute lymphoblastic leukemia - the ECOG-ACRIN E1910 study.

|Mar 06, 2026
Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemia.

Danika Di Giacomo, Petri Pölönen, Valentina Bardelli

|Aug 14, 2025
Venetoclax plus gilteritinib is effective in preclinical models of FLT3-mutant BCL11B-a lineage-ambiguous leukemia.

Lindsey E Montefiori, Ilaria Iacobucci, Qingsong Gao

|Aug 14, 2024
The genomic basis of childhood T-lineage acute lymphoblastic leukaemia.

Petri Pölönen, Danika Di Giacomo, Anna Eames Seffernick

|Jun 25, 2024
Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk.

Shunsuke Kimura, Chun Shik Park, Lindsey E Montefiori

|Feb 22, 2022
Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia.

Shunsuke Kimura, Lindsey Montefiori, Ilaria Iacobucci

Pageof 2

Frequent Collaborators

6 joint publications

Charles G Mullighan

5 joint publications

Ilaria Iacobucci

5 joint publications

Qingsong Gao

4 joint publications

Shunsuke Kimura